Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

697 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
High-risk characteristics of fellow eyes of patients with unilateral neovascular age-related macular degeneration.
Sandberg MA, Weiner A, Miller S, Gaudio AR. Sandberg MA, et al. Among authors: weiner a. Ophthalmology. 1998 Mar;105(3):441-7. doi: 10.1016/S0161-6420(98)93025-1. Ophthalmology. 1998. PMID: 9499774
CONCLUSIONS: A slower recovery from glare and more extensive funduscopic changes appear to be independent risk factors for the development of a CNVM in the fellow eyes of patients with unilateral neovascular AMD. A slower foveal electroretinogram implicit tim …
CONCLUSIONS: A slower recovery from glare and more extensive funduscopic changes appear to be independent risk factors for the develo …
Clinical experience with urgent tube shunt implantation through the ciliary sulcus in phakic eyes.
Weiner AJ, Weiner Y, Severson ML, Weiner A. Weiner AJ, et al. Among authors: weiner y, weiner a. Int Ophthalmol. 2019 Mar;39(3):639-649. doi: 10.1007/s10792-018-0863-9. Epub 2018 Feb 9. Int Ophthalmol. 2019. PMID: 29426968
METHODS: This is a retrospective interventional case series. Three eyes of 3 diabetic patients with uncontrolled severe neovascular glaucoma, shallow anterior chambers with closed angles and poor view to the posterior segment, where concomitant lensectomy was not recommend …
METHODS: This is a retrospective interventional case series. Three eyes of 3 diabetic patients with uncontrolled severe neovascular g …
Foveal cone function in nonproliferative diabetic retinopathy and macular edema.
Weiner A, Christopoulos VA, Gussler CH, Adams DH, Kaufman SR, Kohn HD, Weidenthal DT. Weiner A, et al. Invest Ophthalmol Vis Sci. 1997 Jun;38(7):1443-9. Invest Ophthalmol Vis Sci. 1997. PMID: 9191608
METHODS: Electroretinograms of foveal cones were elicited, with a dual-beam stimulator-ophthalmoscope, from 18 consecutive patients with bilateral NPDR and unilateral CSME. ...These results may support a functional role for outer retinal dysfunction in patients with …
METHODS: Electroretinograms of foveal cones were elicited, with a dual-beam stimulator-ophthalmoscope, from 18 consecutive patients w …
Iris pigmentation and extent of disease in patients with neovascular age-related macular degeneration.
Sandberg MA, Gaudio AR, Miller S, Weiner A. Sandberg MA, et al. Among authors: weiner a. Invest Ophthalmol Vis Sci. 1994 May;35(6):2734-40. Invest Ophthalmol Vis Sci. 1994. PMID: 7514581
In addition, extent of disease in the eye with a CNVM was positively correlated with extent of disease in the fellow eye for most comparisons. ...Furthermore, in such patients, those with worse disease in the eye with a CNVM may tend to have more extensive atrophic …
In addition, extent of disease in the eye with a CNVM was positively correlated with extent of disease in the fellow eye for most com …
Normal change in the foveal cone ERG with increasing duration of light exposure.
Weiner A, Sandberg MA. Weiner A, et al. Invest Ophthalmol Vis Sci. 1991 Sep;32(10):2842-5. Invest Ophthalmol Vis Sci. 1991. PMID: 1894482
Foveal cone electroretinograms (ERG) were elicited with a stimulator-ophthalmoscope from 24 normal subjects with a 4 degrees stimulus flickering at 42 Hz and centered within a 12 degrees steady surround. ...These findings show that a significant change …
Foveal cone electroretinograms (ERG) were elicited with a stimulator-ophthalmoscope from 24 normal subjects with a 4 degrees s …
Hydroxychloroquine retinopathy.
Weiner A, Sandberg MA, Gaudio AR, Kini MM, Berson EL. Weiner A, et al. Am J Ophthalmol. 1991 Nov 15;112(5):528-34. doi: 10.1016/s0002-9394(14)76853-9. Am J Ophthalmol. 1991. PMID: 1951589
Both patients were treated for systemic lupus erythematosus; one patient was treated with 400 to 800 mg of hydroxychloroquine per day (6.1 to 12.2 mg/kg of body weight/day) over a ten-year period. ...Ophthalmoscopy and fluorescein angiography showed a bull's-eye mac …
Both patients were treated for systemic lupus erythematosus; one patient was treated with 400 to 800 mg of hydroxychloroquine per day (6.1 t …
Foveal outer retinal function in eyes with unexplained visual symptoms or acuity loss.
Weiner A, Schmidt ME, Patel S, Gussler CH, Remler BF, Kaufman SR, Kohn HD, Weidenthal DT. Weiner A, et al. Arch Ophthalmol. 1998 Sep;116(9):1161-8. doi: 10.1001/archopht.116.9.1161. Arch Ophthalmol. 1998. PMID: 9747673
CONCLUSION: Foveal outer retinal dysfunction is a common underlying mechanism of previously unexplained visual symptoms or acuity loss. ...
CONCLUSION: Foveal outer retinal dysfunction is a common underlying mechanism of previously unexplained visual symptoms or acuity los …
Foveal dysfunction and central visual field loss in glaucoma.
Weiner A, Ripkin DJ, Patel S, Kaufman SR, Kohn HD, Weidenthal DT. Weiner A, et al. Arch Ophthalmol. 1998 Sep;116(9):1169-74. doi: 10.1001/archopht.116.9.1169. Arch Ophthalmol. 1998. PMID: 9747674
Evaluation of travoprost as adjunctive therapy in patients with uncontrolled intraocular pressure while using timolol 0.5%.
Orengo-Nania S, Landry T, Von Tress M, Silver LH, Weiner A, Davis AA; Travoprost Study Group. Orengo-Nania S, et al. Among authors: weiner a. Am J Ophthalmol. 2001 Dec;132(6):860-8. doi: 10.1016/s0002-9394(01)01257-0. Am J Ophthalmol. 2001. PMID: 11730649 Clinical Trial.
METHODS: Subjects who qualified at screening began a run-in period dosing timolol twice daily for 3 weeks. If the subjects had an intraocular pressure of 24 to 36 mm Hg at 8 AM and 21 to 36 mm Hg at 10 AM and 4 pm in at least one eye on timolol, they were randomized to one …
METHODS: Subjects who qualified at screening began a run-in period dosing timolol twice daily for 3 weeks. If the subjects had an int …
Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.
Netland PA, Landry T, Sullivan EK, Andrew R, Silver L, Weiner A, Mallick S, Dickerson J, Bergamini MV, Robertson SM, Davis AA; Travoprost Study Group. Netland PA, et al. Among authors: weiner a. Am J Ophthalmol. 2001 Oct;132(4):472-84. doi: 10.1016/s0002-9394(01)01177-1. Am J Ophthalmol. 2001. PMID: 11589866 Clinical Trial.
The efficacy and safety of travoprost (0.0015% and 0.004%) daily was compared with latanoprost daily and timolol twice daily for a period of 12 months. ...The average ocular hyperemia score was less than 1 on a scale of 0 to 3, indicating that on average patients ex …
The efficacy and safety of travoprost (0.0015% and 0.004%) daily was compared with latanoprost daily and timolol twice daily for a pe …
697 results
Jump to page
Feedback